Inflammatory bowel disease - Drug treatment and its implications

Hospital Pharmacist

Volumn 13, Issue 5, 2006, Pages 161-166

  Jones, Anja St Clair ^a  

^a UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ALLOPURINOL; AMINOSALICYLIC ACID DERIVATIVE; AMPICILLIN; AZATHIOPRINE; BALSALAZIDE; BUDESONIDE; CEPHALOSPORIN; CORTICOSTEROID; CYCLOSPORIN A; GLUCOCORTICOID; HYDROCORTISONE; HYDROCORTISONE ACETATE; IMMUNOMODULATING AGENT; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; MESREN MR; METHOTREXATE DERIVATIVE; METHYLPREDNISOLONE; METRONIDAZOLE; OLSALAZINE; PREDNISOLONE; PREDNISOLONE 21 PHOSPHATE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; SULFAPYRIDINE; SULFONAMIDE; TIOGUANINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ABDOMINAL PAIN; ACNE; ADRENAL SUPPRESSION; AGRANULOCYTOSIS; ANAPHYLAXIS; BLOOD DYSCRASIA; CROHN DISEASE; CUSHING SYNDROME; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG INHIBITION; DRUG MECHANISM; DRUG SAFETY; DRY SKIN; ENTERITIS; FATIGUE; FEVER; FLU LIKE SYNDROME; GINGIVA HYPERPLASIA; HAIR LOSS; HEADACHE; HIRSUTISM; HUMAN; INFECTION; KIDNEY DISEASE; LEUKAPHERESIS; LEUKOPENIA; LIVER FUNCTION TEST; LIVER TOXICITY; MALAISE; MALE INFERTILITY; MOOD DISORDER; NAUSEA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OSTEOPOROSIS; PANCREATITIS; PANCYTOPENIA; PNEUMONIA; PREGNANCY; PROCTITIS; PRURITUS; RASH; REVIEW; SIDE EFFECT; SLEEP DISORDER; STEVENS JOHNSON SYNDROME; STOMATITIS; TREMOR; TUBERCULOSIS; ULCERATIVE COLITIS;

EID: 33646925444     PISSN: 13527967     EISSN: 13527967     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Carter M, Lobo A, Travis S. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004;53(Suppl V):v1-16.
2. Scott E, Gaywood I, Scott B. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. London: British Society of Gastroenterology; Feb 2000.
3. McIntyre PB, Macrae FA, Berghouse L, English J, Lennard-Jones JE. Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. Gut 1985;26:822-4.
4. Cann PA, Holdsworth CD. Systemic absorption from hydrocortisone foam enema in ulcerative colitis. Lancet 1987;1:922-3.
5. Rodrigues C, Lennard-Jones JE, English J, Parsons DG. Systemic absorption from prednisolone rectal foam in ulcerative colitis. Lancet 1987;1:1497.
6. Nyman-Pantelidis M, Nilsson A, Wagner ZA. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis. Alimentary Pharmacology and Therapeutics 1994;8:617-22.
7. Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. The Cochrane Database of Systematic Reviews 2006;(1):CD000545.
8. Pearson DC, May GR, Fick G, Sutherland LR. Azathioprine for maintenance of remission in Crohn's disease. The Cochrane Database of Systematic Reviews 2006;(1):CD000067.
9. Podolsky D. Inflammatory bowel disease. New England Journal of Medicine 2002;347:417-29.
10. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer FM, Schreiber S, Colombel JF et al. Maintenance infliximab for Crohn's disease: the ACCENT 1 randomised trial. Lancet 2002;340:1398-1405.
11. Sands B, Anderson F, Bernstein C, Lloyd FM, Schreiber S, Colombel JF et al. Infliximab maintenance therapy for fistulizing Crohn's disease New England Journal of Medicine 2004;350:876-85.
12. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J et al. Infliximab for induction and maintenance therapy for ulcerative colitis. New England Journal of Medicine 2005;353:2462-76.
13. Mottet C, Juillerat P, Gonvers J, Froehlich F, Burnard B,Vader JP et al. Pregnancy and Crohn's disease. Digestion 2005;71:45-61.
14. Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut 2005;54:87-90.
15. Summers R, Weinstock D, Urban J, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial. Gastroenterology 2005;128:825-32.
16. Better medicine through biology. Available at www.ovamed.de/english/home/ home.html (accessed 25 April 2006).
17. Van Kruininggen H, West A. Potential danger in the medical use of Trichuris suis for the treatment of inflammatory bowel disease. Inflammatory Bowel Disorders 2005;11:515.
18. Leukapheresis for inflammatory bowel disease. Available at www.nice.org.uk/pdf/ip/IPG126guidance.pdf (accessed 25 April 2006).
19. Hanauer S, Present D. The state of the art in the management of inflammatory bowel disease, Review of Gastroenterology Disorders 2003;39:8-21.